Get the Facts

Substance Use Resources

A blurry image of many medications on shelves
Gavel in front of justice scales and open book

Why

Why are the Attorneys General involved in substance use and the opioid epidemic?

An attorney presenting their argument in court

How

How are the Attorneys General involved in the opioid epidemic and what actions have they taken?

Resources

To learn more about substance use and the role of the Attorneys General, please view our following resources.

The Science of Addiction

Drug addiction is a brain disorder.

What is the Epidemic?

The use and misuse of opioids is one of the deadliest drug epidemics in United States history.

Combatting the Epidemic

Attorneys general are actively leading the charge in combatting the opioid epidemic.

Language Matters

Substance use disorder is one of the most stigmatized medical conditions in the United States.

How States are Responding

State and local governments have worked to hold opioid makers and distributors accountable.

News

A doctor comforting a patient

NAAG Urges DEA and SAMSHA to Extend Telehealth Capabilities

November 17, 2022

A bipartisan group of 45 state attorneys general urge the Drug Enforcement Administration (DEA) and Substance Abuse and Mental Health Services Administration (SAMHSA) to permanently extend telehealth flexibilities after the…

Read More
Image of various prescription bottles

NAAG Asks FDA for Progress Update Under the SUPPORT Act

January 11, 2021

The National Association of Attorneys General (NAAG) sent a letter asking the U.S. Food and Drug Administration (FDA) to examine recent progress in the agency’s fight against the opioid epidemic. NAAG…

Read More
Doctor speaking to patient

NAAG Endorses the Federal Initiative to Guarantee Health by Targeting Act

December 11, 2019

This legislation is crucial to federal and state efforts to curb the opioid epidemic nationally and within each individual state. It is for these reasons that we commend Senators Portman…

Read More

This website is made possible by a grant from the Attorney General Consumer and Prescriber Education Grant Program. The Attorney General Consumer and Prescriber Education Grant Program is funded by the multi-state settlement of consumer fraud claims related to the marketing of the prescription drug Neurontin.  The Consumer and Prescriber Education Grant Program is a fund established through a nationwide consumer protection settlement over off-label marketing of Neurontin. Its mission was to train and educate consumers in issues related to the opioid crisis.